Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000899243-22-031460

Options or other derivatives

  • VP, Finance acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Wong Michael VP, Finance 2022-09-15 Grant or award · Employee Stock Option (right to buy) +50,000 50,000 D
Loading xslF345X03/doc4.xml…